Avosentan
| Title | Journal |
|---|---|
| 2012 update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials. | Minerva medica 20120801 |
| Antidiuretic effects of the endothelin receptor antagonist avosentan. | Frontiers in physiology 20120101 |
| Effect of avosentan (SPP-301) in porcine ciliary arteries. | Current eye research 20110201 |
| Effect of SPP 301, an endothelin antagonist, on intraocular pressure in glaucomatous monkey eyes. | Current eye research 20110101 |
| Diabetic nephropathy - Epidemiology in Asia and the current state of treatment. | Indian journal of nephrology 20110101 |
| Endothelin receptor blockade in patients with diabetic nephropathy. | Contributions to nephrology 20110101 |
| TRC120038, a Novel Dual AT(1)/ET(A) Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 Rats. | International journal of hypertension 20110101 |
| Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse. | Diabetes 20101201 |
| Potential new therapeutic agents for diabetic kidney disease. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20100501 |
| Avosentan for overt diabetic nephropathy. | Journal of the American Society of Nephrology : JASN 20100301 |
| The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice. | Diabetologia 20100101 |
| Channels and transporters. Mini-symposium of the Division of Medicinal Chemistry (DMC) of the Swiss Chemical Society (SCS) at the Department of Chemistry, University of Basel, May 27, 2010. | Chimia 20100101 |
| Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes. | American journal of physiology. Renal physiology 20091101 |
| Absolute bioavailability and pharmacokinetics of avosentan in man. | International journal of clinical pharmacology and therapeutics 20090901 |
| Dose-dependent acute and sustained renal effects of the endothelin receptor antagonist avosentan in healthy subjects. | Clinical pharmacology and therapeutics 20090601 |
| Avosentan reduces albumin excretion in diabetics with macroalbuminuria. | Journal of the American Society of Nephrology : JASN 20090301 |
| Influence of food intake on the pharmacokinetics of avosentan in man. | International journal of clinical pharmacology and therapeutics 20080901 |
| Influence of avosentan (SPP3OI) on the pharmacokinetics of a second generation oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers. | International journal of clinical pharmacology and therapeutics 20061201 |
| Pharmacokinetic interaction between ketoconazole and SPP301 in healthy volunteers. | International journal of clinical pharmacology and therapeutics 20060701 |
| Profile of past and current clinical trials involving endothelin receptor antagonists: the novel '-sentan' class of drug. | Experimental biology and medicine (Maywood, N.J.) 20060601 |